Annual report pursuant to Section 13 and 15(d)

Non-controlling Interest (Details Textual)

v3.8.0.1
Non-controlling Interest (Details Textual) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Aug. 31, 2015
Aug. 29, 2015
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Noncontrolling Interest [Line Items]          
Equity Method Investment, Ownership Percentage     88.50% 88.50%  
Net Loss Attributable to Non-controlling Interest     $ (318) $ (548) $ (1,048)
Noncontrolling Interest, Ownership Percentage by Parent     11.50% 11.50%  
Stockholders Equity Attributable to Noncontrolling Interest     $ (1,914) $ (1,596)  
Consolidation, Eliminations [Member]          
Noncontrolling Interest [Line Items]          
Net Loss Attributable to Non-controlling Interest     548    
Dr. Pimentels [Member]          
Noncontrolling Interest [Line Items]          
Stockholders Equity Attributable to Noncontrolling Interest       $ 1,000  
Dr. Pimentels [Member] | Consolidation, Eliminations [Member]          
Noncontrolling Interest [Line Items]          
Stockholders Equity Attributable to Noncontrolling Interest     $ 505,000    
Biomics and Mark Pimentel [Member]          
Noncontrolling Interest [Line Items]          
Noncontrolling Interest, Ownership Percentage by Parent   8.50%      
Stock Purchase Agreement [Member]          
Noncontrolling Interest [Line Items]          
Conversion of Stock, Shares Issued 1,350,000 1,350,000